![[deamino-Cys1, Val4, D-Arg8]-Vasopressin (CAS 43157-23-9) - chemical structure image](https://media.scbt.com/product/deamino-cys1-val4-d-arg8-vasopressin-43157-23-9-structure_21_75_b_217513.jpg)
![[deamino-Cys1, Val4, D-Arg8]-Vasopressin (CAS 43157-23-9) - chemical structure image](https://media.scbt.com/product/deamino-cys1-val4-d-arg8-vasopressin-43157-23-9-structure_21_75_t_217513.jpg "Molecular structure of [deamino-Cys1, Val4, D-Arg8]-Vasopressin, CAS Number: 43157-23-9")
Molecular structure of [deamino-Cys1, Val4, D-Arg8]-Vasopressin, CAS Number: 43157-23-9
[deamino-Cys1, Val4, D-Arg8]-Vasopressin (CAS 43157-23-9)
Alternate Names:
Val4-dDAVP
CAS Number:
43157-23-9
Molecular Weight:
1040.22
Molecular Formula:
C46H65N13O11S2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
This product displays selective V2 vasopressin receptor agonist activity.
[deamino-Cys1, Val4, D-Arg8]-Vasopressin (CAS 43157-23-9) References
- Small-molecule vasopressin-2 receptor antagonist identified by a g-protein coupled receptor 'pathway' screen. | Yangthara, B., et al. 2007. Mol Pharmacol. 72: 86-94. PMID: 17435162
- Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates. | Louiset, E., et al. 2008. J Endocrinol. 196: 1-9. PMID: 18180312
- Oxytocin-induced contractions within rat and rabbit ejaculatory tissues are mediated by vasopressin V1A receptors and not oxytocin receptors. | Gupta, J., et al. 2008. Br J Pharmacol. 155: 118-26. PMID: 18552879
- DMSO Assisted Electrospray Ionization for the Detection of Small Peptide Hormones in Urine by Dilute-and-Shoot-Liquid-Chromatography-High Resolution Mass Spectrometry. | Judák, P., et al. 2017. J Am Soc Mass Spectrom. 28: 1657-1665. PMID: 28425052
- Emerging drugs to target lower urinary tract symptomatology (LUTS)/benign prostatic hyperplasia (BPH): focus on the prostate. | Ückert, S., et al. 2020. World J Urol. 38: 1423-1435. PMID: 31506747
- Biosafety Level 2 cabinet UV-C light exposure of sports antidoping human urine samples does not affect the stability of selected prohibited substances. | Voss, S., et al. 2021. Drug Test Anal. 13: 460-465. PMID: 33119942
- Doping control analysis of small peptides in human urine using LC-HRMS with parallel reaction monitoring mode: screening and confirmation. | Chang, W., et al. 2021. Anal Methods. 13: 5838-5850. PMID: 34847571
- Multi-analyte screening of small peptides by alkaline pre-activated solid phase extraction coupled with liquid chromatography-high resolution mass spectrometry in doping controls. | Jing, J., et al. 2022. J Chromatogr A. 1676: 463272. PMID: 35802965
- Gastrointestinal absorption and plasma clearance rates of [D-Arg8]vasopressin analogues in the rat. | Lundin, S., et al. 1994. Peptides. 15: 809-14. PMID: 7984498
- Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system. | Croiset, G. and De Wied, D. 1997. Brain Res. 759: 18-23. PMID: 9219858
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
[deamino-Cys1, Val4, D-Arg8]-Vasopressin, 1 mg | sc-300418 | 1 mg | $89.00 |